HNP Capital’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
$2.71M Sell
36,499
-837
-2% -$70.2K 0.76% 33
2022
Q4
$3.48M Sell
37,336
-464
-1% -$44.8K 0.97% 22
2022
Q3
$3.6M Buy
37,800
+7,372
+24% +$730K 1.04% 20
2022
Q2
$2.82M Sell
30,428
-699
-2% -$68.2K 0.78% 34
2022
Q1
$3.15M Sell
31,127
-3,260
-9% -$342K 0.75% 33
2021
Q4
$3.55M Buy
34,387
+268
+0.8% +$24.8K 0.8% 35
2021
Q3
$2.9M Buy
34,119
+383
+1% +$32.1K 0.73% 34
2021
Q2
$2.81M Buy
33,736
+22
+0.1% +$1.8K 0.74% 33
2021
Q1
$2.54M Buy
33,714
+1,542
+5% +$112K 0.75% 36
2020
Q4
$2.2M Buy
32,172
+2,551
+9% +$166K 0.72% 39
2020
Q3
$1.92M Sell
29,621
-220
-0.7% -$13.7K 0.7% 39
2020
Q2
$1.93M Sell
29,841
-36,121
-55% -$2.27M 0.8% 36
2020
Q1
$3.97M Buy
65,962
+47,133
+250% +$3.15M 0.59% 39
2019
Q4
$1.36M Buy
18,829
+9,074
+93% +$637K 0.58% 46
2019
Q3
$597K Buy
9,755
+226
+2% +$13.4K 0.33% 62
2019
Q2
$519K Sell
9,529
-183
-2% -$9.86K 0.3% 67
2019
Q1
$524K Hold
9,712
0.33% 66
2018
Q4
$636K Buy
+9,712
New +$725K 0.43% 54

Other funds holding CVS

HNP Capital's CVS Position: Q1 2023 in Review

HNP Capital reduced its CVS Health (CVS) stake by 2.2% in Q1 2023, selling an estimated $70.2K and leaving 36,499 shares worth $2.71M. The position accounts for 0.76% of the portfolio, ranked #33.

HNP Capital first reported a position in CVS in Q4 2018 and has held it in 18 quarters since. The position peaked at $3.97M in Q1 2020. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • HNP Capital held 36,499 shares of CVS Health worth $2.71M as of Q1 2023.
  • HNP Capital sold 837 CVS Health shares in Q1 2023, an estimated $70.2K.
  • CVS Health made up 0.76% of HNP Capital's portfolio in Q1 2023, its #33 holding.
  • HNP Capital first reported a position in CVS Health in Q4 2018 and has held it in 18 quarters since.
  • HNP Capital's CVS Health position peaked at $3.97M in Q1 2020.
  • 2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on HNP Capital's 13F filing for Q1 2023, filed 18 May 2023.